ZYME
#2006
Zymeworks Inc. - Common Stock
28.2 7 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.55%
Monthly Change
+28.38%
6 month change
+25.37%
Year Change
+59.36%
Previous Close
29.0 1
Open
28.2 7
Low
28.2 7
High
28.2 7
Volume
101
Financials
- Market Capitalization 2.01 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-24.38
Price to sales ratio
18.74
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1994 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +8.10% | +59.78% | 2.04 B USD | ||
| 1996 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 31.27 USD | -4.14% | -3.49% | -0.32% | +18.18% | 2.04 B USD | ||
| 2007 |  NBTX Nanobiotix S.A. - ADSs | 41.23 USD | -8.70% | +1.25% | +7.88% | +397.35% | 2.00 B USD | ||
| 2009 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.68 USD | -8.24% | -10.59% | +16.36% | +221.34% | 1.99 B USD |
Frequently asked questions about Zymeworks Inc.
What is the Zymeworks Inc. stock price today?
The current price of Zymeworks Inc. (ZYME) is 28.27. Over the past 24 hours, the stock has changed by -2.55%. Follow the ZYME chart for real-time price dynamics.
What is the stock ticker of Zymeworks Inc.?
Zymeworks Inc. trades under the ticker ZYME. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zymeworks Inc. stock going up?
ZYME has changed by -1.40% over the last week, +28.38% over the last month, and +59.36% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Zymeworks Inc.?
Zymeworks Inc. currently has a market capitalization of 2.01 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Zymeworks Inc. earnings last quarter?
Last quarter, Zymeworks Inc. reported earnings of -0.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Zymeworks Inc. revenue for the last quarter?
Zymeworks Inc. reported quarterly revenue of 4.59 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Zymeworks Inc. net income for the last quarter?
Zymeworks Inc. reported net income of -45.02 M for the last quarter. The previous quarter showed -44.16 M, which means net income changed by -1.94%.
How many employees does Zymeworks Inc. have?
As of the latest available data, Zymeworks Inc. has 264 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zymeworks Inc. EBITDA?
Zymeworks Inc. EBITDA is -40.78 M, and its EBITDA margin is -888.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zymeworks Inc. stock?
You can buy Zymeworks Inc. (ZYME) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zymeworks Inc. stock?
Investing in Zymeworks Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZYME chart and related analysis on metatrader.com as part of your research.